| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GABRB1 OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRM7 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 3.52e-24 | 884 | 97 | 36 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 1.58e-21 | 431 | 97 | 26 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRM7 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 4.69e-18 | 1353 | 97 | 36 | GO:0004888 |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 SPNS1 TRPC4AP ATP7B ABCA12 SPNS2 MFSD2B SLC12A8 ATP9B NMUR2 ATP9A KCNG3 GRM7 SLCO1B1 SLC7A14 NALCN ABCA5 SLC50A1 SCN9A SCN10A SLC25A53 SLC45A2 MFSD8 SVOP KCNT1 MFSD5 SLC38A3 ABCG5 | 8.67e-12 | 1289 | 97 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 SPNS1 TRPC4AP ATP7B ABCA12 SPNS2 MFSD2B SLC12A8 NMUR2 KCNG3 GRM7 SLCO1B1 SLC7A14 NALCN ABCA5 SLC50A1 SCN9A SCN10A SLC25A53 SLC45A2 MFSD8 SVOP KCNT1 MFSD5 SLC38A3 ABCG5 | 4.26e-11 | 1180 | 97 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | odorant binding | 1.93e-07 | 127 | 97 | 8 | GO:0005549 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 9.39e-07 | 37 | 97 | 5 | GO:0042923 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 TRPC4AP ATP7B SLC12A8 NMUR2 KCNG3 GRM7 NALCN SCN9A SCN10A SLC45A2 MFSD8 KCNT1 MFSD5 SLC38A3 | 3.65e-06 | 758 | 97 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.12e-06 | 196 | 97 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 TRPC4AP ATP7B SLC12A8 NMUR2 KCNG3 GRM7 NALCN SCN9A SCN10A SLC45A2 MFSD8 KCNT1 SLC38A3 | 2.84e-05 | 793 | 97 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 4.69e-05 | 133 | 97 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.25e-05 | 140 | 97 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 TRPC4AP NMUR2 KCNG3 GRM7 NALCN SCN9A SCN10A MFSD8 KCNT1 | 7.88e-05 | 459 | 97 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPC4AP ATP7B SLC12A8 KCNG3 GRM7 NALCN SCN9A SCN10A KCNT1 SLC38A3 | 8.77e-05 | 465 | 97 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.28e-04 | 53 | 97 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 1.39e-04 | 4 | 97 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPC4AP ATP7B SLC12A8 KCNG3 GRM7 NALCN SCN9A SCN10A SLC45A2 KCNT1 SLC38A3 | 2.31e-04 | 627 | 97 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 TRPC4AP NMUR2 KCNG3 GRM7 NALCN SCN9A SCN10A MFSD8 KCNT1 | 2.35e-04 | 525 | 97 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 TRPC4AP NMUR2 KCNG3 GRM7 NALCN SCN9A SCN10A MFSD8 KCNT1 | 2.39e-04 | 526 | 97 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.66e-04 | 26 | 97 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.33e-04 | 28 | 97 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPC4AP ATP7B SLC12A8 KCNG3 GRM7 NALCN SCN9A SCN10A SLC45A2 KCNT1 SLC38A3 | 3.76e-04 | 664 | 97 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.10e-04 | 30 | 97 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.53e-04 | 31 | 97 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7B ABCA12 MFSD2B SLC12A8 SLCO1B1 ABCA5 SLC45A2 SLC38A3 ABCG5 | 5.23e-04 | 477 | 97 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | peptide binding | 9.19e-04 | 318 | 97 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.42e-03 | 343 | 97 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.48e-03 | 171 | 97 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.74e-03 | 49 | 97 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | catecholamine binding | 1.76e-03 | 13 | 97 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.95e-03 | 51 | 97 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.97e-03 | 109 | 97 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | glutamate binding | 2.05e-03 | 14 | 97 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.07e-03 | 52 | 97 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 3.03e-03 | 17 | 97 | 2 | GO:0005545 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.24e-03 | 125 | 97 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 4.19e-03 | 20 | 97 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | proteasome binding | 4.19e-03 | 20 | 97 | 2 | GO:0070628 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 5.63e-22 | 432 | 96 | 26 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 3.62e-21 | 465 | 96 | 26 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 SCN9A SCN10A OR4C12 OR4X1 | 4.74e-21 | 582 | 96 | 28 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 1.04e-20 | 485 | 96 | 26 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 NPY1R OR9G1 OR5M1 OR4C6 OR10P1 SPNS2 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 GRM7 OR1L1 OPRK1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 SCN9A SCN10A SLC45A2 OR4C12 OR4X1 | 6.24e-20 | 1072 | 96 | 34 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 7.19e-20 | 524 | 96 | 26 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 2.09e-19 | 547 | 96 | 26 | GO:0007606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 SPNS2 OR10J6P OR6C74 OR2G2 OR8S1 MFSD2B OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRM7 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 3.43e-19 | 1395 | 96 | 37 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 SCN9A SCN10A OR4C12 OR4X1 | 1.43e-18 | 722 | 96 | 28 | GO:0051606 |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 2.04e-06 | 126 | 96 | 7 | GO:0033555 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 DRD1 TRPC4AP ATP7B SLC12A8 NMUR2 KCNG3 SLCO1B1 PTGS2 OPRK1 PLLP ADRB2 NALCN SCN9A SCN10A UMOD MFSD8 KCNT1 MFSD5 SLC38A3 | 4.24e-06 | 1374 | 96 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | lipid transport | SPNS1 ABCA12 SPNS2 MFSD2B ATP9B NMUR2 ATP9A SLCO1B1 PTGS2 ABCA5 ABCG5 | 2.34e-05 | 506 | 96 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 3.70e-05 | 133 | 96 | 6 | GO:0006939 | |
| GeneOntologyBiologicalProcess | peristalsis | 4.27e-05 | 15 | 96 | 3 | GO:0030432 | |
| GeneOntologyBiologicalProcess | lipid localization | SPNS1 ABCA12 SPNS2 MFSD2B ATP9B NMUR2 ATP9A SLCO1B1 PTGS2 ABCA5 ABCG5 | 6.36e-05 | 565 | 96 | 11 | GO:0010876 |
| GeneOntologyBiologicalProcess | maternal behavior | 7.58e-05 | 18 | 96 | 3 | GO:0042711 | |
| GeneOntologyBiologicalProcess | parental behavior | 1.22e-04 | 21 | 96 | 3 | GO:0060746 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 1.28e-04 | 4 | 96 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 1.31e-04 | 105 | 96 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.78e-04 | 112 | 96 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | grooming behavior | 1.84e-04 | 24 | 96 | 3 | GO:0007625 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 DRD1 TRPC4AP ATP7B SLC12A8 NMUR2 KCNG3 OPRK1 PLLP ADRB2 NALCN SCN9A SCN10A MFSD8 KCNT1 | 1.90e-04 | 1115 | 96 | 15 | GO:0034220 |
| GeneOntologyBiologicalProcess | metal ion transport | DRD1 TRPC4AP ATP7B SLC12A8 KCNG3 PTGS2 OPRK1 ADRB2 NALCN SCN9A SCN10A UMOD KCNT1 SLC38A3 | 2.12e-04 | 1000 | 96 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 2.12e-04 | 5 | 96 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | behavior | DRD1 NPY1R RASGRF1 AVPR1A NMUR2 GRM7 GRPR PTGS2 OPRK1 ADRB2 SCN9A SCN10A MFSD8 | 2.44e-04 | 891 | 96 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 DRD1 TRPC4AP ATP7B SLC12A8 NMUR2 KCNG3 OPRK1 ADRB2 NALCN SCN9A SCN10A MFSD8 KCNT1 | 2.52e-04 | 1017 | 96 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.82e-04 | 272 | 96 | 7 | GO:0006813 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 2.86e-04 | 124 | 96 | 5 | GO:0007218 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 2.97e-04 | 125 | 96 | 5 | GO:0051952 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 3.18e-04 | 6 | 96 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | response to water deprivation | 3.18e-04 | 6 | 96 | 2 | GO:0009414 | |
| GeneOntologyBiologicalProcess | conditioned taste aversion | 3.18e-04 | 6 | 96 | 2 | GO:0001661 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 3.62e-04 | 30 | 96 | 3 | GO:0014821 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 3.82e-04 | 132 | 96 | 5 | GO:0035249 | |
| GeneOntologyBiologicalProcess | amine transport | 4.53e-04 | 137 | 96 | 5 | GO:0015837 | |
| GeneOntologyBiologicalProcess | muscle contraction | 5.59e-04 | 400 | 96 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 5.89e-04 | 8 | 96 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 6.57e-04 | 410 | 96 | 8 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 6.79e-04 | 412 | 96 | 8 | GO:0015849 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 6.99e-04 | 86 | 96 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 7.32e-04 | 38 | 96 | 3 | GO:0050951 | |
| GeneOntologyBiologicalProcess | positive regulation of prostaglandin biosynthetic process | 7.56e-04 | 9 | 96 | 2 | GO:0031394 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 9.00e-04 | 92 | 96 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | DRD1 TRPC4AP ATP7B SLC12A8 KCNG3 PTGS2 OPRK1 ADRB2 NALCN SCN9A SCN10A UMOD KCNT1 SLC38A3 | 9.08e-04 | 1157 | 96 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 9.42e-04 | 10 | 96 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | feeding behavior | 9.66e-04 | 162 | 96 | 5 | GO:0007631 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 9.66e-04 | 162 | 96 | 5 | GO:0015748 | |
| GeneOntologyBiologicalProcess | positive regulation of behavior | 1.05e-03 | 43 | 96 | 3 | GO:0048520 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 1.05e-03 | 43 | 96 | 3 | GO:0051968 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 1.14e-03 | 98 | 96 | 4 | GO:0019229 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 1.15e-03 | 11 | 96 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | positive regulation of unsaturated fatty acid biosynthetic process | 1.15e-03 | 11 | 96 | 2 | GO:2001280 | |
| GeneOntologyCellularComponent | presynaptic membrane | 5.71e-06 | 277 | 97 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GAD2 DRD1 LRFN1 NPY1R IQSEC2 GRM7 DNAJC6 OPRK1 ADRB2 SCN10A KCNT1 | 1.63e-05 | 583 | 97 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | 5.96e-04 | 405 | 97 | 8 | GO:0045211 | |
| HumanPheno | Pruritus | 4.93e-05 | 149 | 24 | 6 | HP:0000989 | |
| HumanPheno | Aggressive behavior | ATP7B ABCA12 IQSEC2 ATP9A GRM7 DNAJC6 NALCN SCN9A KCNT1 SLC38A3 | 5.50e-05 | 516 | 24 | 10 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | ATP7B ABCA12 IQSEC2 ATP9A GRM7 DNAJC6 NALCN SCN9A KCNT1 SLC38A3 | 5.50e-05 | 516 | 24 | 10 | HP:0006919 |
| MousePheno | abnormal synaptic physiology | GABRB1 GAD2 SPNS1 DRD1 MBOAT1 RASGRF1 AVPR1A TNC IQSEC2 ATP9A SSTR2 GRM7 PTGS2 OPRK1 NALCN SCN9A KCNT1 | 2.75e-06 | 1076 | 62 | 17 | MP:0021009 |
| MousePheno | abnormal synaptic transmission | GABRB1 GAD2 SPNS1 MBOAT1 RASGRF1 AVPR1A TNC IQSEC2 ATP9A SSTR2 GRM7 PTGS2 OPRK1 NALCN SCN9A KCNT1 | 1.17e-05 | 1070 | 62 | 16 | MP:0003635 |
| MousePheno | abnormal avoidance learning behavior | 5.90e-05 | 94 | 62 | 5 | MP:0001462 | |
| MousePheno | abnormal behavioral response to xenobiotic | 6.24e-05 | 309 | 62 | 8 | MP:0009745 | |
| MousePheno | decreased sphingosine level | 1.15e-04 | 4 | 62 | 2 | MP:0020117 | |
| MousePheno | hyperactivity | GAD2 DRD1 NPY1R RASGRF1 TNC ST7 IQSEC2 TMEM104 ATP9A GRM7 GRPR TMEM33 MIGA2 SLC45A2 KCNT1 | 1.40e-04 | 1172 | 62 | 15 | MP:0001399 |
| MousePheno | stomatocytosis | 1.92e-04 | 5 | 62 | 2 | MP:0010074 | |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 6.46e-23 | 670 | 95 | 32 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 8.87e-23 | 677 | 95 | 32 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 1.27e-22 | 685 | 95 | 32 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 1.65e-22 | 691 | 95 | 32 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 DRD1 NPY1R OR9G1 OR5M1 AVPR1A OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 NMUR2 SSTR2 GRPR OR1L1 OPRK1 OR1L8 ADRB2 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 1.73e-22 | 692 | 95 | 32 | IPR000276 |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 1.41e-19 | 393 | 95 | 24 | IPR000725 |
| Domain | 7TM_GPCR_Srsx | 1.02e-07 | 112 | 95 | 8 | SM01381 | |
| Domain | MFS_dom | 4.09e-07 | 134 | 95 | 8 | IPR020846 | |
| Domain | MFS | 1.29e-06 | 108 | 95 | 7 | PS50850 | |
| Domain | MFS_1 | 4.53e-05 | 77 | 95 | 5 | PF07690 | |
| Domain | MFS | 4.53e-05 | 77 | 95 | 5 | IPR011701 | |
| Domain | Channel_four-helix_dom | 2.02e-04 | 57 | 95 | 4 | IPR027359 | |
| Domain | - | 2.02e-04 | 57 | 95 | 4 | 1.20.120.350 | |
| Domain | IQ | 4.70e-04 | 71 | 95 | 4 | PF00612 | |
| Domain | - | 5.68e-04 | 32 | 95 | 3 | 3.40.1110.10 | |
| Domain | - | 5.68e-04 | 32 | 95 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 7.42e-04 | 35 | 95 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 8.06e-04 | 36 | 95 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 8.06e-04 | 36 | 95 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 8.06e-04 | 36 | 95 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.74e-04 | 37 | 95 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.74e-04 | 37 | 95 | 3 | PF00122 | |
| Domain | Na_channel_asu | 1.12e-03 | 10 | 95 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.12e-03 | 10 | 95 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.12e-03 | 10 | 95 | 2 | PF06512 | |
| Domain | IQ_motif_EF-hand-BS | 1.15e-03 | 90 | 95 | 4 | IPR000048 | |
| Domain | IQ | 1.30e-03 | 93 | 95 | 4 | PS50096 | |
| Domain | ABC_A | 1.63e-03 | 12 | 95 | 2 | IPR026082 | |
| Domain | ABC_tran | 1.87e-03 | 48 | 95 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.87e-03 | 48 | 95 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.98e-03 | 49 | 95 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 2.10e-03 | 50 | 95 | 3 | IPR003439 | |
| Domain | P_typ_ATPase_c | 2.24e-03 | 14 | 95 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.24e-03 | 14 | 95 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.24e-03 | 14 | 95 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.24e-03 | 14 | 95 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.24e-03 | 14 | 95 | 2 | PF16209 | |
| Domain | Ion_trans_dom | 2.74e-03 | 114 | 95 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.74e-03 | 114 | 95 | 4 | PF00520 | |
| Domain | Aa_trans | 3.31e-03 | 17 | 95 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 3.31e-03 | 17 | 95 | 2 | IPR013057 | |
| Domain | EGF | 3.92e-03 | 126 | 95 | 4 | PF00008 | |
| Domain | - | 4.24e-03 | 64 | 95 | 3 | 3.40.50.1000 | |
| Domain | AA-permease/SLC12A_dom | 5.53e-03 | 22 | 95 | 2 | IPR004841 | |
| Domain | AA_permease | 5.53e-03 | 22 | 95 | 2 | PF00324 | |
| Domain | HAD-like_dom | 7.63e-03 | 79 | 95 | 3 | IPR023214 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 1.36e-18 | 417 | 77 | 24 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 OR4C12 OR4X1 | 4.49e-18 | 389 | 77 | 23 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR2G2 OR8S1 OR5K4 OR10H4 OR8H1 OR1L1 OR1L8 OR5AC2 OR2T6 OR10H3 OR51M1 OR1Q1 SCN9A OR4C12 OR4X1 | 1.83e-15 | 636 | 77 | 25 | M41834 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.42e-06 | 260 | 77 | 10 | M39397 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.13e-06 | 272 | 77 | 10 | M13380 | |
| Pathway | WP_GPCRS_NONODORANT | 1.39e-05 | 266 | 77 | 9 | MM15843 | |
| Pathway | WP_GPCRS_PEPTIDE | 3.91e-05 | 70 | 77 | 5 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 5.46e-05 | 75 | 77 | 5 | M39696 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.01e-04 | 17 | 77 | 3 | MM14552 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.21e-04 | 18 | 77 | 3 | M524 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPC4AP ATP7B ABCA12 ATP9B ATP9A SLCO1B1 PSME4 NALCN ABCA5 SLC50A1 SLC38A3 ABCG5 | 3.00e-04 | 681 | 77 | 12 | MM14985 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.28e-04 | 330 | 77 | 8 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.55e-04 | 333 | 77 | 8 | MM14963 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.31e-04 | 186 | 77 | 6 | MM15994 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 5.41e-04 | 430 | 77 | 9 | MM15160 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPC4AP ATP7B ABCA12 ATP9B ATP9A SLCO1B1 PSME4 NALCN ABCA5 SLC50A1 SLC38A3 ABCG5 | 6.04e-04 | 736 | 77 | 12 | M27287 |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 6.73e-04 | 73 | 77 | 4 | MM16641 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.18e-04 | 197 | 77 | 6 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.18e-04 | 197 | 77 | 6 | MM14970 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 9.16e-04 | 463 | 77 | 9 | M507 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR8S1 OR5K4 OR10H4 OR8H1 OR1L8 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 | 1.37e-19 | 340 | 97 | 19 | 11875048 |
| Pubmed | OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR8S1 OR5K4 OR10H4 OR8H1 OR1L8 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 | 1.37e-19 | 340 | 97 | 19 | 11802173 | |
| Pubmed | OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR8S1 OR5K4 OR10H4 OR8H1 OR1L8 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 | 1.62e-19 | 343 | 97 | 19 | 32295537 | |
| Pubmed | OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR6C74 OR8S1 OR5K4 OR10H4 OR8H1 OR1L8 OR2T6 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 | 1.91e-19 | 346 | 97 | 19 | 14611657 | |
| Pubmed | OR8I2 OR7G1 OR5M10 OR9G1 OR5M1 OR4C6 OR10P1 OR10J6P OR6C74 OR2G2 OR10H4 OR8H1 OR1L1 OR1L8 OR10H3 OR51M1 OR1Q1 OR5H8 OR4C12 OR4X1 | 4.37e-17 | 541 | 97 | 20 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR8I2 OR7G1 OR5M1 OR10P1 OR10J6P OR10H4 OR1L8 OR2T6 OR1Q1 OR4C12 | 6.22e-10 | 219 | 97 | 10 | 12213199 |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 8.41e-08 | 130 | 97 | 7 | 19874574 | |
| Pubmed | 1.10e-07 | 81 | 97 | 6 | 22723691 | ||
| Pubmed | Non-canonical Opioid Signaling Inhibits Itch Transmission in the Spinal Cord of Mice. | 7.30e-07 | 7 | 97 | 3 | 29669290 | |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 8.27e-07 | 182 | 97 | 7 | 20468064 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.28e-06 | 67 | 97 | 5 | 16987237 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26098693 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 7.70e-06 | 2 | 97 | 2 | 19415763 | |
| Pubmed | Tissue and zonal-specific expression of an olfactory receptor transgene. | 7.70e-06 | 2 | 97 | 2 | 9412503 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15980630 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 7.70e-06 | 2 | 97 | 2 | 16111501 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30354807 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15741608 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24598770 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 7.70e-06 | 2 | 97 | 2 | 22079639 | |
| Pubmed | Direct uptake of sphingosine-1-phosphate independent of phospholipid phosphatases. | 7.70e-06 | 2 | 97 | 2 | 33785361 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 7.70e-06 | 2 | 97 | 2 | 21136380 | |
| Pubmed | 2.15e-05 | 200 | 97 | 6 | 18240029 | ||
| Pubmed | 2.19e-05 | 300 | 97 | 7 | 19086053 | ||
| Pubmed | Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent. | 2.31e-05 | 3 | 97 | 2 | 20395378 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 2.31e-05 | 3 | 97 | 2 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 2.31e-05 | 3 | 97 | 2 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 2.31e-05 | 3 | 97 | 2 | 18177668 | |
| Pubmed | The cell and molecular basis of mechanical, cold, and inflammatory pain. | 2.31e-05 | 3 | 97 | 2 | 18669863 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 2.31e-05 | 3 | 97 | 2 | 17211451 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 15502159 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 2.31e-05 | 3 | 97 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 2.31e-05 | 3 | 97 | 2 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 2.31e-05 | 3 | 97 | 2 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 2.31e-05 | 3 | 97 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 2.31e-05 | 3 | 97 | 2 | 23329853 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 2.31e-05 | 3 | 97 | 2 | 26733157 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22449024 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 2.31e-05 | 3 | 97 | 2 | 19582141 | |
| Pubmed | Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. | 2.31e-05 | 3 | 97 | 2 | 22875917 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 2.31e-05 | 3 | 97 | 2 | 28636920 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20539761 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18584034 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21969378 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20661723 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 29245050 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 2.31e-05 | 3 | 97 | 2 | 15494369 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 2.31e-05 | 3 | 97 | 2 | 14728807 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 2.31e-05 | 3 | 97 | 2 | 21194951 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22388986 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16791199 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 38999942 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 2.31e-05 | 3 | 97 | 2 | 18024963 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 27125671 | ||
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 2.31e-05 | 3 | 97 | 2 | 25410303 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 33334884 | ||
| Pubmed | Sepsis induces an increase in thick ascending limb Cox-2 that is TLR4 dependent. | 2.31e-05 | 3 | 97 | 2 | 17634395 | |
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 2.31e-05 | 3 | 97 | 2 | 17360937 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 2.31e-05 | 3 | 97 | 2 | 24461999 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18455532 | ||
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 2.31e-05 | 3 | 97 | 2 | 30837263 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 2.31e-05 | 3 | 97 | 2 | 27939294 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18442017 | ||
| Pubmed | Accumbal D1R Neurons Projecting to Lateral Hypothalamus Authorize Feeding. | 2.31e-05 | 3 | 97 | 2 | 26593092 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 2.31e-05 | 3 | 97 | 2 | 22172669 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 2.31e-05 | 3 | 97 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 2.31e-05 | 3 | 97 | 2 | 17554338 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 2.31e-05 | 3 | 97 | 2 | 16259959 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12609610 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 24227785 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31425733 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 2.31e-05 | 3 | 97 | 2 | 23770853 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 2.31e-05 | 3 | 97 | 2 | 24527385 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18086680 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 17204467 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23200040 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 2.31e-05 | 3 | 97 | 2 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 2.31e-05 | 3 | 97 | 2 | 17352742 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19699781 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 2.31e-05 | 3 | 97 | 2 | 25005472 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16773043 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23071603 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19538012 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21119109 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 32145514 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 2.31e-05 | 3 | 97 | 2 | 18097409 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 2.31e-05 | 3 | 97 | 2 | 25753417 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22337995 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 2.31e-05 | 3 | 97 | 2 | 23333380 | |
| Interaction | PTGER1 interactions | 7.08e-06 | 10 | 80 | 3 | int:PTGER1 | |
| Interaction | SCN11A interactions | 2.65e-05 | 15 | 80 | 3 | int:SCN11A | |
| Cytoband | 3q12.1 | 1.18e-05 | 21 | 97 | 3 | 3q12.1 | |
| Cytoband | 11q12.1 | 2.48e-05 | 161 | 97 | 5 | 11q12.1 | |
| Cytoband | 9q33.2 | 7.91e-05 | 39 | 97 | 3 | 9q33.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 9.59e-05 | 345 | 97 | 6 | chr11q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 2.10e-04 | 54 | 97 | 3 | chr3q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 2.18e-04 | 138 | 97 | 4 | chr9q33 | |
| GeneFamily | Olfactory receptors, family 5 | 1.16e-04 | 112 | 77 | 5 | 152 | |
| GeneFamily | Olfactory receptors, family 10 | 1.79e-04 | 66 | 77 | 4 | 157 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.32e-04 | 9 | 77 | 2 | 1203 | |
| GeneFamily | Olfactory receptors, family 1 | 6.55e-04 | 40 | 77 | 3 | 147 | |
| GeneFamily | Olfactory receptors, family 51 | 8.68e-04 | 44 | 77 | 3 | 164 | |
| GeneFamily | Olfactory receptors, family 8 | 1.19e-03 | 49 | 77 | 3 | 155 | |
| GeneFamily | Solute carriers | 1.46e-03 | 395 | 77 | 7 | 752 | |
| GeneFamily | ATP binding cassette subfamily A | 1.58e-03 | 14 | 77 | 2 | 805 | |
| GeneFamily | ATPase phospholipid transporting | 1.81e-03 | 15 | 77 | 2 | 1210 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GABRB1 GAD2 NPY1R ATP9A GRM7 DNAJC6 SLC7A14 NALCN SCN9A FAM169A MCF2L SVOP | 5.75e-06 | 703 | 91 | 12 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 2.70e-05 | 450 | 91 | 9 | M39072 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GABRB1 ATP9A SSTR2 DNAJC6 OPRK1 NALCN SCN9A FAM169A MCF2L SVOP | 3.56e-05 | 584 | 91 | 10 | M39068 |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 4.48e-06 | 200 | 95 | 6 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 4.48e-06 | 200 | 95 | 6 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 4.48e-06 | 200 | 95 | 6 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| ToppCell | mLN-(7)_Mast_cell|mLN / shred on region, Cell_type, and subtype | 4.48e-06 | 200 | 95 | 6 | 13bca944fbdbc0be6687eca82c62a4d231ab94f0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.93e-05 | 153 | 95 | 5 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| Computational | Genes in the cancer module 146. | 1.37e-07 | 102 | 43 | 7 | MODULE_146 | |
| Computational | Genes in the cancer module 288. | 1.33e-05 | 37 | 43 | 4 | MODULE_288 | |
| Computational | Genes in the cancer module 289. | 1.28e-04 | 124 | 43 | 5 | MODULE_289 | |
| Computational | Genes in the cancer module 134. | 2.25e-04 | 30 | 43 | 3 | MODULE_134 | |
| Computational | GPCR signaling pathways (immune and neuro). | 4.42e-04 | 90 | 43 | 4 | MODULE_375 | |
| Computational | Membranal receptors. | 8.86e-04 | 517 | 43 | 8 | MODULE_64 | |
| Drug | tetradotoxin | GABRB1 GAD2 DRD1 GRM7 PTGS2 ITIH4 OPRK1 ADRB2 SCN9A SCN10A SLC45A2 | 1.55e-06 | 428 | 94 | 11 | CID000020382 |
| Drug | Picrotoxin | 2.56e-06 | 94 | 94 | 6 | ctd:D010852 | |
| Disease | Generalized seizures | 1.41e-05 | 101 | 89 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.41e-05 | 101 | 89 | 5 | C0234535 | |
| Disease | Convulsive Seizures | 1.41e-05 | 101 | 89 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.41e-05 | 101 | 89 | 5 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.41e-05 | 101 | 89 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.41e-05 | 101 | 89 | 5 | C0751123 | |
| Disease | Complex partial seizures | 1.41e-05 | 101 | 89 | 5 | C0149958 | |
| Disease | Single Seizure | 1.41e-05 | 101 | 89 | 5 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.41e-05 | 101 | 89 | 5 | C3495874 | |
| Disease | Visual seizure | 1.41e-05 | 101 | 89 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.41e-05 | 101 | 89 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.41e-05 | 101 | 89 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.41e-05 | 101 | 89 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.41e-05 | 101 | 89 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.41e-05 | 101 | 89 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.41e-05 | 101 | 89 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.41e-05 | 101 | 89 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 1.41e-05 | 101 | 89 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 1.41e-05 | 101 | 89 | 5 | C4317109 | |
| Disease | Absence Seizures | 1.47e-05 | 102 | 89 | 5 | C4316903 | |
| Disease | Convulsions | 1.47e-05 | 102 | 89 | 5 | C4048158 | |
| Disease | Tonic Seizures | 1.47e-05 | 102 | 89 | 5 | C0270844 | |
| Disease | Seizures, Focal | 1.62e-05 | 104 | 89 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 1.62e-05 | 104 | 89 | 5 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.62e-05 | 104 | 89 | 5 | C0494475 | |
| Disease | Primary Erythermalgia | 2.69e-05 | 3 | 89 | 2 | C0014805 | |
| Disease | sphingolipidosis (implicated_via_orthology) | 2.69e-05 | 3 | 89 | 2 | DOID:1927 (implicated_via_orthology) | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.69e-05 | 3 | 89 | 2 | C1833661 | |
| Disease | acute kidney failure (implicated_via_orthology) | 7.36e-05 | 27 | 89 | 3 | DOID:3021 (implicated_via_orthology) | |
| Disease | octadecenedioate (C18:1-DC) measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0800563 | |
| Disease | octadecenedioylcarnitine (C18:1-DC) measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0800370 | |
| Disease | Congenital Pain Insensitivity | 1.87e-04 | 7 | 89 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.87e-04 | 7 | 89 | 2 | C0020075 | |
| Disease | octadecanedioylcarnitine (C18-DC) measurement | 1.87e-04 | 7 | 89 | 2 | EFO_0800371 | |
| Disease | Depressive disorder | 2.47e-04 | 289 | 89 | 6 | C0011581 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.98e-04 | 10 | 89 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.98e-04 | 10 | 89 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | octadecanedioate measurement | 3.98e-04 | 10 | 89 | 2 | EFO_0021056 | |
| Disease | Cocaine-Related Disorders | 4.42e-04 | 117 | 89 | 4 | C0236736 | |
| Disease | colon cancer (implicated_via_orthology) | 4.86e-04 | 11 | 89 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Seizures | 5.27e-04 | 218 | 89 | 5 | C0036572 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.82e-04 | 12 | 89 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Cocaine Abuse | 6.02e-04 | 127 | 89 | 4 | C0009171 | |
| Disease | Bipolar Disorder | 6.08e-04 | 477 | 89 | 7 | C0005586 | |
| Disease | factor VII measurement | 6.21e-04 | 55 | 89 | 3 | EFO_0004619 | |
| Disease | sensory peripheral neuropathy, response to platinum based chemotherapy | 6.87e-04 | 13 | 89 | 2 | EFO_0004647, MONDO_0002321 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 8.00e-04 | 14 | 89 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Cocaine Dependence | 8.44e-04 | 139 | 89 | 4 | C0600427 | |
| Disease | Dyskinesia, Medication-Induced | 9.21e-04 | 15 | 89 | 2 | C0751088 | |
| Disease | Dyskinesia, Drug-Induced | 9.21e-04 | 15 | 89 | 2 | C0013386 | |
| Disease | obesity (biomarker_via_orthology) | 1.04e-03 | 147 | 89 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Mental Depression | 1.05e-03 | 254 | 89 | 5 | C0011570 | |
| Disease | Neuralgia, Supraorbital | 1.05e-03 | 16 | 89 | 2 | C0038870 | |
| Disease | Neuralgia | 1.05e-03 | 16 | 89 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 1.05e-03 | 16 | 89 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.05e-03 | 16 | 89 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.05e-03 | 16 | 89 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.05e-03 | 16 | 89 | 2 | C0423711 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.05e-03 | 16 | 89 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.05e-03 | 16 | 89 | 2 | C2713443 | |
| Disease | Paroxysmal Nerve Pain | 1.05e-03 | 16 | 89 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.05e-03 | 16 | 89 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.05e-03 | 16 | 89 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.05e-03 | 16 | 89 | 2 | C0042656 | |
| Disease | Autistic Disorder | 1.18e-03 | 261 | 89 | 5 | C0004352 | |
| Disease | Adenomatous Polyposis Coli | 1.19e-03 | 17 | 89 | 2 | C0032580 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.33e-03 | 157 | 89 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 1.33e-03 | 268 | 89 | 5 | C0001973 | |
| Disease | epilepsy (implicated_via_orthology) | 1.52e-03 | 163 | 89 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.65e-03 | 20 | 89 | 2 | DOID:3328 (is_marker_for) | |
| Disease | depressive disorder (implicated_via_orthology) | 2.00e-03 | 22 | 89 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.00e-03 | 22 | 89 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | drug-induced liver injury | 2.38e-03 | 24 | 89 | 2 | EFO_0004228 | |
| Disease | Dyslipidemias | 2.38e-03 | 24 | 89 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.38e-03 | 24 | 89 | 2 | C0598784 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.58e-03 | 90 | 89 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Cardiac Arrhythmia | 2.58e-03 | 25 | 89 | 2 | C0003811 | |
| Disease | cystic fibrosis (is_implicated_in) | 3.01e-03 | 27 | 89 | 2 | DOID:1485 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFNSTMVYSLPILVN | 971 | Q8WWZ7 | |
| NVILPIMFSSLYRIS | 381 | Q16537 | |
| PISVYLLFNAMTALT | 6 | Q6UW88 | |
| FISMIFRLDYTQPLS | 61 | Q6P093 | |
| IASSIVSFYVPLVIM | 201 | P07550 | |
| SGYFVPFIIIMSTLT | 921 | P35670 | |
| FLTSVSYSLPIVLMV | 1061 | Q86UK0 | |
| ISSSVISFYIPVAIM | 196 | P21728 | |
| AYSFVTPLTSMVVTK | 581 | Q14624 | |
| SKIIAVFYTFLSPML | 271 | Q6IEU7 | |
| KIVSTFYTVVFPMLN | 271 | Q8NH87 | |
| PLVLMIFNISATVLY | 101 | Q9Y342 | |
| QINMYTTPVLLSAFL | 206 | Q8NHS3 | |
| MVESLFYTVIIPFLN | 271 | P0DN80 | |
| AITPYYISVLMTVFT | 261 | Q8TAE7 | |
| QVASVFYTIVIPMLN | 271 | Q8N0Y5 | |
| NTNMFTYEIAPVFVL | 201 | Q05329 | |
| FVSLFYTVVTRMLNP | 276 | Q8NGZ5 | |
| TITTSQALSSPMYFF | 46 | Q96R67 | |
| IIQVTSFLFYLLPMT | 216 | Q9GZQ4 | |
| SFLFYLLPMTVISVL | 221 | Q9GZQ4 | |
| LVYRMIPSTSQTFLV | 466 | Q9P244 | |
| TIYTMFPVFSLVLDQ | 971 | O43861 | |
| LVTYSFRQSFPLVEM | 1016 | Q5JU85 | |
| VQTMFRLFPSLSITT | 886 | Q5JUK3 | |
| MLLIPFSVVTASYTR | 206 | Q8NHC8 | |
| FMLLSNITQFSPIFY | 11 | Q9H341 | |
| TILASKVLTSPMYFF | 46 | Q8NH49 | |
| TRYFSTPQTMDLFLN | 281 | Q9H9S0 | |
| IPFLRNAIMSYVLTS | 91 | P35354 | |
| ATFFQVPYTALTMLL | 156 | A6NFX1 | |
| AMTVAEIPVFLYTTF | 16 | Q7L4E1 | |
| FILQTYMPSTLITIL | 246 | P18505 | |
| MTFSIIELFISLPFS | 171 | Q9H3V2 | |
| STIYTMFPVFSLVLD | 881 | O75110 | |
| TSYVEITTFFLVGMP | 6 | Q8NGJ7 | |
| TSYVEITTFFLVGMP | 6 | Q8NGJ6 | |
| PQLLTTLMFQVFYNS | 421 | Q5TGP6 | |
| NVLAAISPYFRSMFT | 66 | Q8NFY9 | |
| FTTVYIPKFLVSMAT | 71 | A6NCV1 | |
| MATTYTVFTPFLSPI | 276 | O60404 | |
| MATTYTVFTPFLSPI | 276 | Q8NGA5 | |
| SDTRLQTPMYFFLSI | 101 | Q8NH94 | |
| MSSYFVNSTFPVTLA | 1 | P17509 | |
| AFIQIPTLMTIIISY | 206 | Q9NZP5 | |
| IPFSLFLSMYLVTIL | 26 | Q8NGA0 | |
| AVASSLPFLIYQVMT | 166 | P25929 | |
| SMASFLVFYVIPLSI | 211 | P30550 | |
| FTYVTSRIIVMSFPL | 66 | O75061 | |
| TMNFLILYSFIPALV | 621 | Q9H222 | |
| PSVYNFVTMINFTVT | 2596 | Q0VDD8 | |
| LTQSYQLPVLDTMFL | 171 | Q9Y6X4 | |
| QLAVSYTVAPFVMLA | 431 | Q6ZNC8 | |
| FQNVMTYLTSIPSLQ | 111 | O15068 | |
| IFVMATFIRYNDTPI | 606 | Q14831 | |
| IFVQSLIPFYVATSM | 241 | Q3SXM5 | |
| NVLAPIVTINFMLTY | 381 | A0AV02 | |
| FGVMSSTLYTVPFNL | 431 | Q9UMX9 | |
| IVVFSLFMLTFSTSP | 321 | Q6N075 | |
| QVASVFYTIVIPMLN | 271 | Q8NGG4 | |
| IVYTVLSSMLNPFIY | 276 | Q8NGR8 | |
| TVYTLFIIPQMLSSF | 71 | Q8NGY7 | |
| VFIMIPFSLIVTSYI | 206 | Q8NGE3 | |
| ALVTTTMPFQSTVYL | 106 | P41145 | |
| MLQIIFSPTKVISYT | 81 | Q15612 | |
| TIITSQSLRSPMYFF | 46 | Q8NH72 | |
| PFIAQVMLESSVYLT | 476 | Q8N4V2 | |
| TLNSQTAYTIPIMAF | 281 | Q99624 | |
| LAYISQVPTQMSFLF | 656 | Q8TEL6 | |
| TRYFSTPQTMDLFLN | 281 | Q6NSW7 | |
| SKITAVFYTFLSPML | 271 | Q8NGP8 | |
| VPLQYVFVMTFTLDD | 536 | Q9NUX5 | |
| TIFRFNATPALYMLS | 96 | Q15858 | |
| TRTLMLSVFYFAIPL | 226 | Q8IVW8 | |
| LVTVATMFFQYLLQP | 231 | Q8TF30 | |
| VSNFMSTFLTFPIYK | 36 | Q5H9E4 | |
| VSMFLNTLTPKFYVA | 51 | Q9NRC1 | |
| IFSVQYTVVTPMLNS | 271 | Q8NH09 | |
| YTVVTPMLNSLIYSL | 276 | Q8NH09 | |
| ELMIYIFSIPIQIFT | 196 | A6NMS3 | |
| ERTLETFLTYPMFQI | 371 | Q13972 | |
| PFYIFNVSSVSMAIS | 271 | P30874 | |
| FQSFKSILTNPLYVM | 326 | Q9Y6L6 | |
| SILTNPLYVMFVLLT | 331 | Q9Y6L6 | |
| VSVSVILTLMVPYYT | 301 | Q8TBB6 | |
| VASYLVRMEPFTQIF | 2796 | Q8IZQ1 | |
| FTVRMALFQTPSYTQ | 456 | P07911 | |
| FFTTYIIISFLIMVN | 1701 | Q9Y5Y9 | |
| QTVFISSYMVLAPVF | 101 | Q9H2V7 | |
| YIMVSNFPGIVTSFI | 186 | Q9BRV3 | |
| MIQTIFTTIGLLYPF | 1966 | P24821 | |
| AIYAAAVPFSLMQVT | 161 | Q8NE00 | |
| EIFSSLQPFRSQVYM | 1986 | Q5JSZ5 | |
| ASILNMPLVTTLFYS | 326 | Q9H9C1 | |
| TFPFIMLTSPNFILS | 86 | Q6UWH6 | |
| TMQKAITYFEIFLPT | 206 | Q14997 | |
| LSTPQYFVFSMIEVN | 181 | P37288 | |
| YLSSVMQAIFSIPEF | 346 | Q92995 | |
| LLYSLIFVNSYPVTM | 96 | P57088 | |
| PLQYVTFTLDTLLMF | 66 | Q8IZF0 | |
| PTLQIAEYVFVIFMS | 916 | Q8IZF0 |